Synaura
Shanghai
About Synaura
Synaura manufactures, supplies, and develops human milk oligosaccharides (HMO) for breastfed infants. The company specializes in biosynthesis technology and provides baby formula that has the same nutritional value as breast milk, allowing customers to use HMO products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Total funding: $13.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2024)
- Website: synaura.cn
- Phone: +86-18753935700
Industries & Categories
Health Care, Medical, Nutrition
Social Profiles
Canonical: https://fsome.com/organization/synaura-145590 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.